Ann Arbor Bio Research Private Limited
Provides R&D services for pharmaceutical, biotech, and medical device industries since 2007.
2007 | Hyderabad, Telangana (India) | Active
Ann Arbor Bio Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -106.75%
- Ebitda -105.37%
- Net Worth -49.24%
- Total Assets -85.52%
About Ann Arbor Bio Research
Ann Arbor Bio Research Private Limited (AABRPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2007 and has a history of 17 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharma, Kommineni Ranjit, Vikas Kommineni, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TG2007PTC055921
- Company No.
055921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Travel and Hospitality
Who are the key members and board of directors at Ann Arbor Bio Research?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Saraswat  | Director | 25-Jul-2018 | Current |
| Neeraj Sharma | Whole-Time Director | 15-Oct-2007 | Current |
| Kommineni Ranjit | Director | 15-Oct-2007 | Current |
| Vikas Kommineni | Director | 21-Jan-2008 | Current |
Financial Performance of Ann Arbor Bio Research.
Ann Arbor Bio Research Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 106.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ann Arbor Bio Research?
In 2018, Ann Arbor Bio Research had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Oluma International Designs Private Limited
Neeraj Sharma is a mutual person
- Nvs Bio Research Private Limited
Neeraj Sharma is a mutual person
- Orissa Power Consortium Limited
Vikas Kommineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ann Arbor Bio Research?
Unlock and access historical data on people associated with Ann Arbor Bio Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ann Arbor Bio Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ann Arbor Bio Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
